Neurologist David Geldmacher, M.D., is  launching a new clinical effort to prepare a personalized dementia risk assessment for people concerned about their risk for developing memory problems as they age.
He has been an active member of the American Parkinson Disease Association Scientific Advisory Board since May 2001 and is the board’s fourth chairman since the organization’s founding in 1961.